NCT07073742View on ClinicalTrials.gov

CLaCS Using 0.2% Aetoxysklerol Foam and 70% Glucose for the Treatment of Lower Limb Telangiectasias

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

September 1, 2027

Study Completion Date

September 1, 2028

Conditions
Varicose Veins of Lower LimbSpider VeinsReticular Leg Veins
Interventions
PROCEDURE

CLaCS

CLaCS is hybrid outpatient procedure combining Nd:YAG 1064 nm laser treatment with injection of a sclerosant (either 70% glucose or 0.2% polidocanol foam).

All Listed Sponsors
lead

Charles University, Czech Republic

OTHER